OIS VIRTUAL PUBLIC COMPANY SHOWCASE
July 16, 2020
Day
Hour
Minute
Second
The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
OIS Index Rallies Back from COVID-Driven Decline
The OIS Index of ophthalmic stocks staged a strong comeback in Q2, gaining 21.4%, in line with the overall US stock market as measured by ...
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
Weeks after completing its acquisition of Allergan, AbbVie is seeking a meeting with the US Food and Drug Administration to talk about the next steps ...
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
Oyster Point Pharma has taken two big steps recently to advance development of its OC-01 nasal-spray candidate to treat dry eye disease: the closing of ...
Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists
Collaborative care models – optometrists and ophthalmologists working together on patient care – are emerging as a way to reduce some of the strain caused ...
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena
Most transformations are predictable: A caterpillar will turn into a butterfly; a cell will be genetically altered should extraneous DNA enter its membrane. Predictable would ...
May Extends April’s Rebound from March Lows
The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.